Probenecid

丙磺舒

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameProbenecid
Drug Alias Name璜舒Probenecidum黄舒羧苯磺丙胺羧苯磺胺 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 2C9 inhibitorsOrganic Anion Transporter 3 inhibitorsUric acid transporter 1 inhibitors +[4] 
TargetsCytochrome P450 2C9Organic Anion Transporter 3Uric acid transporter 1 +[4] 
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)CravingAlcohol Abstinence +[10] 
Global Approved IndicationsHyperuricemiaGout
Approved Indications in ChinaGout
Original Approved Country/TerritoryUnited States
Original Approved Date1951/04/26
Country/TerritoryCanadaUnited StatesIndia +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesTrippBio IncBrown UniversityUniversity Of Calgary +[6] 
Inactive CompaniesMerck & Co IncUniversity Of Cincinnati
Active IndicationsCoronavirus Disease 2019 (COVID-19)CravingAlcohol Abstinence +[8] 
Inactive IndicationsHyperuricemiaHeart Failure, Systolic

Other Information

ATC CodeM04AB01
Related LinksWikipediaDrugBankKEGG